Our goal is to establish basic science foundations and engineering principles for the broad applications of theranostic (therapeutic+diagnostic) nano-objects, defined as compact autonomous molecular devices capable of analyzing multiple biomarkers before signaling that there are pathological events or before taking corrective actions. Our effort will center on methods to control behavior of dynamic """"""""neggs"""""""" (nano-eggs), made of deoxyribonucleic acids, and comprising sensors, imaging and/or therapeutic moieties, and molecular computing functions. Neggs can open (be unlocked) or close (be locked) on cue, and this cue can be integrated information on the presence or absence of one or more biomarkers. In order to showcase the transformative potential of theranostic nano-objects, we will map increasingly complex engineered behaviors of neggs to proof-of-concepts for therapeutic applications for which no other existing technologies are satisfactory. For example, we will: (i) open a negg if an analyte raises above (e.g., glucose) or drops below (e.g., vasopressin) its """"""""normal"""""""" concentration;(ii) mark for elimination/imaging narrow subpopulations of cells based on multiple surface markers, while protecting cells that differ in a single marker (e.g., on lymphocytes);and (iii) demonstrate amplification of MRI contrast agents on a targeted cell type (exemplified on b-cells). 1

Public Health Relevance

Theranostic (therapeutic+diagnostic) nano-objects are autonomous nanoscopic devices capable of analyzing in vivo multiple biomarkers before signaling the presence of pathological events (imaging/diagnostics) or before taking corrective actions when needed (therapeutics). They can autonomously control levels of glucose in diabetes, prevent irreversible shock in an intensive care patient, or selectively eliminate very narrow subpopulations of cells in a cancer patient.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-BCMB-A (51))
Program Officer
Lewis, Catherine D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University
Internal Medicine/Medicine
Schools of Medicine
New York
United States
Zip Code
Kim, Jinho; Olsen, Timothy R; Zhu, Jing et al. (2016) Integrated Microfluidic Isolation of Aptamers Using Electrophoretic Oligonucleotide Manipulation. Sci Rep 6:26139
Zhao, Zhao; Fu, Jinglin; Dhakal, Soma et al. (2016) Nanocaged enzymes with enhanced catalytic activity and increased stability against protease digestion. Nat Commun 7:10619
Yang, Kyung-Ae; Pei, Renjun; Stojanovic, Milan N (2016) In vitro selection and amplification protocols for isolation of aptameric sensors for small molecules. Methods 106:58-65
Yang, Kyung-Ae; Barbu, Mihaela; Halim, Marlin et al. (2014) Recognition and sensing of low-epitope targets via ternary complexes with oligonucleotides and synthetic receptors. Nat Chem 6:1003-8
Taylor, Steven K; Wang, Jingxian; Kostic, Natasa et al. (2013) Monovalent streptavidin that senses oligonucleotides. Angew Chem Int Ed Engl 52:5509-12
Rudchenko, Maria; Taylor, Steven; Pallavi, Payal et al. (2013) Autonomous molecular cascades for evaluation of cell surfaces. Nat Nanotechnol 8:580-6